Siemens Medical Systems has been active in forming alliances for its PACS program. At the Healthcare Information and Management Systems Society conference in February, the Iselin, NJ-based vendor entered into a strategic alliance with RIS firm IDX
Siemens Medical Systems has been active in forming alliances for its PACS program. At the Healthcare Information and Management Systems Society conference in February, the Iselin, NJ-based vendor entered into a strategic alliance with RIS firm IDX Systems. The two companies had been working together at the Cleveland Clinic, where they have integrated the multimodality vendors PACS and modality network with IDXs IDXrad RIS offering.
The nonexclusive agreement allows each company to jointly participate in marketing, sales, and installation efforts in North America. As a result of their collaboration at the Cleveland Clinic, Siemens and Burlington, VT-based IDX say they have achieved true integration of RIS and PACS, and have eliminated the need for a traditional PACS/RIS interface.
The agreement isnt the only PACS partnership announced by Siemens recently. The company has also formed a nonexclusive co-marketing agreement with archiving firm StorageTek. Staff from both Siemens and Louisville, CO-based StorageTek will meet jointly with clients in complicated PACS purchasing situations, according to the firms.
Improving Adherence to Best Practices for Incidental Abdominal Aortic Aneurysms on CT and MRI
November 5th 2024In recent interviews, Eric Rohren, M.D., and Krishna Nallamshetty, M.D., discuss the potential of abdominal aortic aneurysms (AAAs) to progress into life-threatening consequences and an emerging AI-powered tool that may bolster adherence to best practice recommendations in radiology reporting of incidental AAA findings on CT and MRI.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).